The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer.
Divoux J, Florent R, Jacobs M, Lequesne J, Grellard JM, San C, Grossi S, Kerdja K, Clarisse B, Boudier G, Cherifi F, Briand M, Dolivet E, Johnson A, Dubois B, Harter V, Lacroix J, Raboutet C, Marie B, Rousseau N, Blanc-Fournier C, Vaur D, Figeac M, Poulain L, Weiswald LB, Emile G.
Divoux J, et al. Among authors: san c.
BMC Cancer. 2023 Sep 19;23(1):883. doi: 10.1186/s12885-023-11362-8.
BMC Cancer. 2023.
PMID: 37726786
Free PMC article.